XML 49 R25.htm IDEA: XBRL DOCUMENT v3.25.1
Shares
 12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
Shares Shares
a) Common shares
Common sharesTreasury sharesCommon shares, net of treasury shares
Issued and outstanding at December 31, 202227,827,282 (1,406,461)26,420,821 
Purchase of treasury shares— (20,955)(20,955)
Settlement of certain equity classified stock-based compensation— 337,229 337,229 
Issued and outstanding at December 31, 202327,827,282 (1,090,187)26,737,095 
Issued upon conversion of convertible debentures26,576 — 26,576 
Retired through share purchase program(149,408)— (149,408)
Purchase of treasury shares— (15,641)(15,641)
Settlement of certain equity classified stock-based compensation— 105,500 105,500 
Issued and outstanding at December 31, 202427,704,450 (1,000,328)26,704,122 
Upon settlement of certain equity classified stock-based compensation during the year ended December 31, 2024, the Company withheld the cash equivalent of 76,542 shares for $2,019 to satisfy the recipient tax withholding requirements (year ended December 31, 2023 - 234,728 shares for $5,479).
b) Net income per share
Year ended December 31, 20242023
Net income$44,085 $63,141 
Interest from convertible debentures (after tax)5,998 5,925 
Diluted net income available to common shareholders$50,083 $69,066 
Weighted-average number of common shares26,772,113 26,566,846 
Weighted-average effect of dilutive securities
Dilutive effect of treasury shares1,048,551 1,260,436 
Dilutive effect of 5.00% convertible debentures
2,174,773 2,148,438 
Dilutive effect of 5.50% convertible debentures
3,058,440 3,051,020 
Weighted-average number of diluted common shares33,053,877 33,026,740 
Basic net income per share$1.65 $2.38 
Diluted net income per share$1.52 $2.09 
For the years ended December 31, 2024, and December 31, 2023, all securities were dilutive.
c) Share purchase program
On November 4, 2024, the Company commenced a normal course issuer bid ("NCIB") under which a maximum number of 2,087,577 common shares were authorized to be purchased. During the year ended December 31, 2024, the Company purchased and subsequently cancelled 149,408 shares under this NCIB, which resulted in a decrease to common shares of $1,138 and a decrease to additional paid-in capital of $3,173. To support the NCIB, the Company entered into an automatic share purchase plan with a designated broker on January 7, 2025. This plan allows for the purchase of up to 2,087,577 common shares until the NCIB’s expiry on November 3, 2025.
Subsequent to the year ended December 31, 2024, as of March 14, 2025, the Company purchased and subsequently cancelled 55,000 shares under this NCIB, which resulted in a decrease of common shares of $492 and an increase to additional paid-in capital of $830.
d) Dividends
Date declaredPer shareShareholders on record as ofPaid or payable to shareholdersTotal paid or payable
Q1 2023February 14, 2023$0.10 March 3, 2023April 6, 2023$2,621 
Q2 2023April 25, 2023$0.10 May 26, 2023July 7, 2023$2,641 
Q3 2023July 25, 2023$0.10 August 31, 2023October 6, 2023$2,674 
Q4 2023October 31, 2023$0.10 November 30, 2023January 5, 2024$2,674 
Q1 2024February 20, 2024$0.10 March 8, 2024April 5, 2024$2,673 
Q2 2024April 30, 2024$0.10 May 31, 2024July 5, 2024$2,673 
Q3 2024July 31, 2024$0.10 August 30, 2024October 4, 2024$2,624 
Q4 2024October 29, 2024$0.12 November 27, 2024January 5, 2025$3,022